Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-03-17
2010-10-26
Crane, Lawrence E (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S027300
Reexamination Certificate
active
07820637
ABSTRACT:
5′-methylthioadenosine (MTA), its pharmaceutically acceptable salts and/or prodrugs may be used in the prevention and/or treatment of autoimmune diseases, such as, for example, Multiple Sclerosis (MS), as well as in the prevention and/or treatment of transplant rejection.
REFERENCES:
patent: 6555518 (2003-04-01), Margreiter et al.
patent: 0352609 (1990-01-01), None
patent: 2074446 (1981-11-01), None
patent: 9816184 (1998-04-01), None
patent: 03028712 (2003-04-01), None
Hevia et al., “5′-Methylthioadenosine Modulates the Inflammatory Response to Endotoxin in Mice and in Rat Hepatocytes,” Hepatology, vol. 39, No. 4., (2004), pp. 1088-1098.
Mowen et al., “Arginine Methylation of NIP45 Modulates Cytokine Gene Expression in Effector T Lymphocytes,” Molecular Cell, vol. 15, (Aug. 27, 2004), pp. 559-571.
Cohen, Philip L., Systemic Autoimmunity, Fundamental Immunology, W. E. Paul (ed.), 5th edition, 2003, pp. 1371-1399, Chapter 44.
Davidson, Anne., M.B., B.S., et al., Autoimmune Diseases, New England Journal of Medicine, 2001, pp. 340-350, vol. 345, No. 5.
Janeway, C., et al., Autoimmunity: responses to self antigens, Immunobiology, 2004, 6th Ed., Garland Publ. Inc., New York.
Rosenberg, Helene F., et al., Inflammation, Fundamental Immunology, W.E. Paul (ed.) 5th edition, 2003, pp. 1151-1169.
Liu, Eric H., et al., T cell-directed therapies: lessons learned and future prospects, Nature Immunology, 2007, pp. 25-30, vol. 8, No. 1.
Santana, Maria Angelica, et al., Cell Biology of T Cell Activation and Differentiation, International Review of Cytology, 2006, pp. 217-274, vol. 250.
Bruna Beatriz Moreno
Díaz Pablo Villoslada
García-Trevijano Elena Ruiz
Izquierdo Fernando Corrales
Lasarte Carmen Berasain
Crane Lawrence E
Fuierer Tristan A.
Gerschutz Andrew D.
Moore & Van Allen PLLC
Proyecto de Biomedicina Cima, S.L.
LandOfFree
Use of 5′-methylthioadenosine (MTA) in the prevention... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 5′-methylthioadenosine (MTA) in the prevention..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 5′-methylthioadenosine (MTA) in the prevention... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4226056